Assessment of maggot debridement therapy for leg ulcer

Assessment of maggot debridement therapy for leg ulcer - Assessment of maggot debridement therapy for leg ulcer

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006165

Enrollment

Registered

2011-08-15

Start date

2011-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leg ulcer

Interventions

Maggot debridement therapy: 48hr

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient with leg ulcer

Exclusion criteria

Exclusion criteria: 1) no evidence of leg ulcer, 2) unable to obtain informed consent, 3) smoker unable to quit smoking, 4) drug addiction of any kind (including alcohol), 5) complication of any serious disease affecting the patient's general condition

Design outcomes

Primary

Measure	Time frame
Impact of maggot debridement therapy for severity and prognosis of leg ulcer	—

Secondary

Measure	Time frame
Clinical parameter in response to maggot debridement therapy	—

Countries

Japan

Contacts

Public ContactGen Takagi

Nippon Medical School Department of Cardiovascular Medicine

miyamoto-m@nms.ac.jp03-3822-2131

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026